Submitted by Anonymous (not verified) on 14 November 2024 - 9:59
Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 12, Status: Authorised